Vanguard Group Inc I Teos Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITOS
# of Institutions
152Shares Held
36.3MCall Options Held
653KPut Options Held
1.48M-
Black Rock Inc. New York, NY3.73MShares$32.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.52MShares$31 Million0.79% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.25MShares$28.6 Million1.7% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$26 Million2.43% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$24.1 Million22.32% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $313M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...